Eli Lilly, Novo Nordisk and Trump
Digest more
1hon MSN
Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, media reports
Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...
Eli Lilly and Company (NYSE:LLY) shares are trading slightly lower on Tuesday after its previous gains following reports ...
The Trump administration has spent much of this year working to coerce drugmakers into lowering their prices in the U.S. | ...
Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...
Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.
The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback